IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose–dependently activated via IL-36β and induces CD4+ lymphocyte proliferation-Reference-Cited by-同舟云学术

IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose–dependently activated via IL-36β and induces CD4+ lymphocyte proliferation

Published:2016-09 Issue: Volume:85 Page:18-25
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Penha Rafael,Higgins John,Mutamba Shilla,Barrow Paul,Mahida Yashwant,Foster Neil

Funder

Nottingham University studentship

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference26 articles.

1. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation;Blumberg;J. Exp. Med.,2007

2. IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells;Vigne;Blood,2012

3. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk;Tortola;J. Clin. Invest.,2012

4. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis;Marrakchi;N. Engl. J. Med.,2011

5. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants;Sugiura;J. Derm. Sci.,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Porcine Monocyte DNA Traps Formed during Infection with Pathogenic Clostridioides difficile Strains;Pathogens;2024-03-05

2. Interleukin-36 receptor antagonist stimulation in vitro inhibits peripheral and lung-resident T cell response isolated from patients with ventilator-associated pneumonia;International Immunopharmacology;2024-03

3. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases;Journal of Investigative Dermatology;2024-02

4. Regularized survival learning and cross-database analysis enabled identification of colorectal cancer prognosis-related immune genes;Frontiers in Genetics;2023-02-23

5. IL-1RAP, a Key Therapeutic Target in Cancer;International Journal of Molecular Sciences;2022-11-29